Recreational ecstasy use and depression (Q48598854)

13 February 2018

title

Recreational ecstasy use and depression (English)

1 reference

13 February 2018

author name string

Casey Guillot

series ordinal

1

1 reference

13 February 2018

David Greenway

series ordinal

2

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

13 February 2018

Journal of Psychopharmacology

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 February 2018

volume

20

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

411-416

1 reference

13 February 2018

EGOCENTRISM AND DEPRESSIVE SYMPTOMATOLOGY IN YOUNG ADULTS

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

The content of ecstasy tablets: implications for the study of their long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Characteristics of ecstasy users in Sãio Paulo, Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Personality dimensions and psychopathological profiles of Ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Subjective reports of the effects of MDMA in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Mental disorders in ecstasy users: a prospective-longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

The Beck Inventory: psychometric properties in university students

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Caveat emptor: editors beware

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Chronic MDMA (ecstasy) use, cognition and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

The Beck Depression Inventory and self-reports of behavior over a ten-day period

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory-Second Edition in a sample of college students

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Caveat emptor: editors beware

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Impaired executive function in male MDMA ("ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

Estimating WAIS-R IQ from the Shipley Institute of Living Scale: a replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063265

21 January 2018

Identifiers

DOI

10.1177/0269881106063265

1 reference

13 February 2018

1 reference

13 February 2018